The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Chemoreduction in the Initial Management of Intraocular Retinoblastoma
Abstract
BACKGROUND: Chemoreduction is a method of reducing tumor volume to allow for more focused, less damaging therapeutic measures. OBJECTIVE: To determine whether chemoreduction could be used to decrease the size of retinoblastoma so that enucleation or external beam radiotherapy could be avoided and more conservative modalities employed. METHODS: A prospective pilot study was performed to assess the effectiveness of a 2-month chemoreduction regimen of vincristine sulfate, etoposide, and carboplatin in patients with retinoblastoma. The study included 20 patients with 54 tumors in 31 eyes. RESULTS: At the initial examination, the mean tumor base was 12 mm and the thickness, 7 mm. Vitreous seeds were present in 14 eyes (45%). A secondary retinal detachment was present in 24 eyes (77%) and, when present, involved a mean of 71% of the retina. In 11 eyes (36%) the retina was totally detached with serous subretinal fluid. After 2 months of chemoreduction, all 54 tumors showed regression in size, and 48 (89%) showed evidence of calcification. The mean tumor base was 8 mm and the thickness, 4 mm. Overall, there was a mean 35% decrease in base and 49% decrease in thickness of the tumor at the end of the treatment period. A complete response was found in 25 tumors (46%) and a partial response in 29 (54%). The subretinal fluid had resolved completely in 50% of the cases (12/24 eyes), and, in the 11 eyes with total retinal detachment, the subretinal fluid had completely resolved, leaving flat retina, in 6 eyes (54%). The vitreous seeds demonstrated some degree of regression in all cases, and in 5 eyes there was 90% to 100% calcification of the seeds. Short-term systemic toxic effects were mild (transient bone marrow suppression). Enucleation was avoided in all cases; external beam radiotherapy was necessary in 9 eyes because of diffuse vitreous seeds. The remaining 22 eyes were treated with local methods after chemoreduction. CONCLUSION: Tumor shrinkage with chemoreduction may allow treatment with less invasive measures, such as cryotherapy, laser photocoagulation, thermotherapy, or plaque radiotherapy, thereby avoiding enucleation and external beam radiotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone Sarcomas Linked to Radiotherapy and Chemotherapy in Children
Tucker, M. A., D'Angio, G. J., Boice, J. D., Strong, L. C., Li, F. P., Stovall, M., Stone, B. J., Green, D. M., Lombardi, F., Newton, W., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198709033171002 · Cited by 765
Mortality From Second Tumors Among Long-Term Survivors of Retinoblastoma
Eng, C., Li, F. P., Abramson, D. H., Ellsworth, R. M., Wong, F. L., Goldman, M. B., Seddon, J., Tarbell, N., & Boice, J. D. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.14.1121 · Cited by 568
Second primary neoplasms in patients with retinoblastoma
Draper, G. J., Sanders, B. M., & Kingston, J. E. (1986) · British Journal of Cancer · doi:10.1038/bjc.1986.110 · Cited by 554
Second Nonocular Tumors in Retinoblastoma Survivors
Abramson, D. H., Ellsworth, R. M., Kitchin, F. D., & Tung, G. (1984) · Ophthalmology · doi:10.1016/s0161-6420(84)34127-6 · Cited by 436
Intraocular Tumors: A Text and Atlas
Shields, J. A., & Shields, C. L. (1992) · Medical Entomology and Zoology · Cited by 337
Self-citationIncidence of Second Neoplasms in Patients with Bilateral Retinoblastoma
Roarty, J. D., McLean, I. W., & Zimmerman, L. E. (1988) · Ophthalmology · doi:10.1016/s0161-6420(88)32971-4 · Cited by 253
RADIATION INDUCED NEOPLASIA FOLLOWING EXTERNAL BEAM THERAPY FOR CHILDREN WITH RETINOBLASTOMA
SAGERMAN, R. H., CASSADY, J. R., TRETTER, P., & ELLSWORTH, R. M. (1969) · American Journal of Roentgenology · doi:10.2214/ajr.105.3.529 · Cited by 222
Retinoblastoma in Great Britain 1969-80: incidence, treatment, and survival.
Sanders, B. M., Draper, G. J., & Kingston, J. E. (1988) · British Journal of Ophthalmology · doi:10.1136/bjo.72.8.576 · Cited by 202
Inomata, M., & Kaneko, A. (1987) · PubMed · Cited by 142
THE EXPANDING ROLE OF LASER PHOTOCOAGULATION FOR INTRAOCULAR TUMORS
Shields, J. A. (1994) · Retina · doi:10.1097/00006982-199414040-00004 · Cited by 66
Cited by
Shields, C. L., & Shields, J. A. (2010) · Current Opinion in Ophthalmology · doi:10.1097/icu.0b013e328338676a · Cited by 280
Self-citationChemoreduction and Local Ophthalmic Therapy for Intraocular Retinoblastoma
Friedman, D. L., Himelstein, B., Shields, C. L., Shields, J. A., Needle, M., Miller, D., Bunin, G. R., & Meadows, A. T. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.1.12 · Cited by 267
Self-citationChévez-Barrios, P., Chintagumpala, M., Mieler, W., Paysse, E., Boniuk, M., Kozinetz, C., Hurwitz, M. Y., & Hurwitz, R. L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.1883 · Cited by 143
Metadata
- Authors
- Shields, C. L.
- Venue
- Archives of Ophthalmology
- Publisher
- American Medical Association (AMA)
- Published
- 1996-11-01
- Volume
- 114
- Issue
- 11
- Pages
- 1330
- ISSN
- 0003-9950 (ISSN-L)
- OpenAlex
- W2045388751
- Cited by
- 360
- References
- 11
- FWCI
- 19.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chemoreduction in the Initial Management of Intraocular Retinoblastoma. https://app.cochat.ai/papers/10.1001/archopht.1996.01100140530002
- The paper
- Shields, C. L. (1996). Chemoreduction in the Initial Management of Intraocular Retinoblastoma. Archives of Ophthalmology. https://doi.org/10.1001/archopht.1996.01100140530002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.